Home/Filings/4/0001628908-21-000036
4//SEC Filing

Shams Aammaad 4

Accession 0001628908-21-000036

CIK 0001628908other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 8:54 PM ET

Size

4.8 KB

Accession

0001628908-21-000036

Insider Transaction Report

Form 4
Period: 2021-03-01
Shams Aammaad
Chief Accounting Officer
Transactions
  • Award

    Class A Common Stock

    2021-03-01+15,00015,000 total
Footnotes (2)
  • [F1]Represents restricted stock units granted to Mr. Shams pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
  • [F2]Securities vest at a rate of 25% annually beginning March 1, 2022.

Issuer

Evolent Health, Inc.

CIK 0001628908

Entity typeother

Related Parties

1
  • filerCIK 0001815354

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 8:54 PM ET
Size
4.8 KB